Post-traumatic Stress Disorder Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Demographics (Adult, Children), By Distribution Channel, By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global post-traumatic stress disorder treatment market size was exhibited at USD 1.26 billion in 2022 and is projected to hit around USD 2.01 billion by 2032, growing at a CAGR of 4.8% during the forecast period 2023 to 2032.

post-traumatic stress disorder treatment market size

Key Pointers:

  • North America dominated the PTSD treatment market and accounted for the largest revenue share of 58.9% in 2022.
  • In 2022, antidepressants segment accounted for the largest share and is anticipated to maintain its position over the forecast period owing to FDA approved SSRIs such as Zoloft (sertraline) and Paxil (paroxetine)
  • Based on demographics, adult segment is estimated to witness the fastest CAGR of 5.3% during the forecast period owing to presence of rising disorder incidence in adult group, major chunk of patients in this age group and increase in traumatic experiences
  • The retail pharmacy segment dominated the market and accounted for the largest revenue share of 65.9% over the forecast period.
  • Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increased awareness among the population, rise in disposable income, and high disease prevalence of PTSD in developing countries

 Post-traumatic Stress Disorder Treatment Market Report Scope

Report Coverage

Details

Market Size in 2023

USD 1.32 Billion

Market Size by 2032

USD 2.01 Billion

Growth Rate from 2023 to 2032

CAGR of 4.8%

Base year

2022

Forecast period

2023 to 2032

Segments covered

Drug Class, demographics, distribution channel

Regional scope

North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa

Key companies profiled

Lupin Limited; Pfizer, Inc.; Aurobindo Pharma Limited; Merck KGaA; GlaxoSmithKline plc.; Otsuka Pharmaceutical Development; Jazz Pharmaceuticals; Bionomics; Aptinyx; AstraZeneca

 

The major factor driving the market includes robust late stage product pipeline and increasing R&D for development of novel therapies pertaining to treatment. Moreover, global rise in burden of post-traumatic stress disorder (PTSD) cases is primarily driving the market. For instance, according to PTSD Statistics and Facts article, about 8 million Americans are suffering from the condition in 2022.

The upsurge in incidence of post-traumatic stress disorder is such that one in 13 people develop this disorder once in lifetime. According to NCBI article, 70% of adult Americans experience at least one traumatic event out of which 20% develop PTSD due to such events. The prevalence of this condition is more common in women than in men due to sexual violence and rape victims which is the leading cause of traumatic experiences. Its prevalence rate among women is around 9.7%, compared to about 3.6% in men. Furthermore, rising incidences of natural and manmade disasters, such as the COVID-19 pandemic and the Russian-Ukraine war, further support the cases.

The increasing demand for better therapeutic options is leading to innovation in R&D, and the introduction of new therapeutic drugs, thereby creating a lucrative opportunity for market growth over the forecast period. For instance, Otsuka Pharmaceutical Development Inc.’s Brexpiprazole and Zoloft Combination is in phase 3 investigation for PTSD. Furthermore, Jazz Pharmaceuticals’ JZP150, Aptinyx’s NYX-783, and Bionomics’ BNC210 are under phase 2 clinical investigation, such factors are expected drive the space growth over the forecast period.

However, side effects associated with post-traumatic stress disorder therapeutics, such as drug abuse, is expected to restrain the space growth over the forecast period.

Post-traumatic Stress Disorder Treatment Market Segmentation

By Drug Class By  Demographics By  Distribution Channel
  • Antidepressants
  • Antipsychotics
  • Anti-anxiety
  • Others
  • Adult
  • Children
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

Frequently Asked Questions

The global post-traumatic stress disorder treatment market size was exhibited at USD 1.26 billion in 2022 and is projected to hit around USD 2.01 billion by 2032

Some key players operating in the post-traumatic stress disorder treatment market include GlaxoSmithKline plc.; Otsuka Pharmaceutical Development; Jazz Pharmaceuticals; Bionomics; Aptinyx; AstraZeneca

Key factors that are driving the post-traumatic stress disorder treatment market growth include robust product pipeline, rising prevalence of PTSD, and increasing awareness about mental health.

Chapter 1 Methodology And Scope
                   1.1 Market Segmentation And Scope
                       1.1.1 Segment Scope
                       1.1.2 Regional Scope
                       1.1.3 Estimates And Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database:
                       1.3.2 Nova one advisor’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                   1.4 Information Or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis
                           1.6.1.1 Approach: Commodity Flow Approach
                   1.7 Research Assumptions
                   1.8 List Of Secondary Sources
                   1.9 List Of Abbreviations
                   1.10 Objectives
                       1.10.1 Objective 1
                       1.10.2 Objective 2
                       1.10.3 Objective 3
                       1.10.4 Objective 4
Chapter 2 Executive Summary
                   2.1 Market Outlook
Chapter 3 Post-Traumatic Stress Disorder Treatment Market Variables, Trends, And Scope
                   3.1 Penetration And Growth Prospect Mapping
                   3.2 User Perspective Analysis
                   3.3 Regulatory And Reimbursement Framework
                   3.4 Market Driver Analysis
                       3.4.1 Rising Prevalence Of The Ptsd
                       3.4.2 Increasing R&D For Development Of New Therapies
                   3.5 Market Restraint Analysis
                       3.5.1 Side Effects Associated With Drugs
                   3.6 Covid-19 Impact Analysis
                   3.7 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
                   3.8 Industry Analysis – Porter’s
Chapter 4 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Drug Class, 2020 - 2032
                   4.1 Post-Traumatic Stress Disorder Treatment Market: Drug Class Movement Analysis
                   4.2 Antidepressants
                       4.2.1 Antidepressants Market, 2020 - 2032
                   4.3 Antipsychotics
                       4.3.1 Antipsychotics Market, 2020 - 2032
                   4.4 Anti-Anxiety
                       4.4.1 Anti-Anxiety Market, 2020 - 2032
                   4.5 Others
                       4.5.1 Others Market, 2020 - 2032
Chapter 5 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Demographics, 2020 - 2032
                   5.1 Post-Traumatic Stress Disorder Treatment Market: Demographics Movement Analysis
                   5.2 Adult
                       5.2.1 Adult Market, 2020 - 2032
                   5.3 Children
                       5.3.1 Children Market, 2020 - 2032
Chapter 6 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Distribution Channel, 2020 - 2032
                   6.1 Post-Traumatic Stress Disorder Treatment Market: Distribution Channel Movement Analysis
                   6.2 Hospital Pharmacy
                       6.2.1 Hospital Pharmacy Market, 2020 - 2032
                   6.3 Retail Pharmacy
                       6.3.1 Retail Pharmacy Market, 2020 - 2032
                   6.4 Others
                       6.4.1 Others Market, 2020 - 2032
Chapter 7 Post-Traumatic Stress Disorder Treatment Market: Segment Analysis, By Region, 2020 - 2032
                   7.1 Definition & Scope
                   7.2 Regional Market Share Analysis, 2023 & 2032
                   7.3 Regional Market Snapshot
                   7.4 Market Size, & Forecasts, Revenue And Trend Analysis, 2023 to 2032
                       7.4.1 North America
                           7.4.1.1 North America Market Estimates And Forecast, 2020 - 2032
                           7.4.1.2 U.S.
                               7.4.1.2.1 U.S. Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.1.3 Canada
                               7.4.1.3.1 Canada Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                       7.4.2 Europe
                           7.4.2.1 Europe Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.2.2 U.K.
                               7.4.2.2.1 Uk Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.2.3 Germany
                               7.4.2.3.1 Germany Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.2.4 France
                               7.4.2.4.1 France Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.2.5 Spain
                               7.4.2.5.1 Spain Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.2.6 Italy
                               7.4.2.6.1 Italy Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                       7.4.3 Asia Pacific
                           7.4.3.1 Asia Pacific Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.3.2 Japan
                               7.4.3.2.1 Japan Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.3.3 China
                               7.4.3.3.1 China Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.3.4 India
                               7.4.3.4.1 India Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.3.5 Australia
                               7.4.3.5.1 Australia Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.3.6 South Korea
                               7.4.3.6.1 South Korea Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                       7.4.4 Latin America
                           7.4.4.1 Latin America Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.4.2 Brazil
                               7.4.4.2.1 Brazil Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.4.3 Mexico
                               7.4.4.3.1 Mexico Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.4.4 Argentina
                               7.4.4.4.1 Argentina Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                       7.4.5 Middle East & Africa
                           7.4.5.1 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.5.2 South Africa
                               7.4.5.2.1 South Africa Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.5.3 Saudi Arabia
                               7.4.5.3.1 Saudi Arabia Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
                           7.4.5.4 UAE
                               7.4.5.4.1 UAE Post-Traumatic Stress Disorder Treatment Market, 2020 - 2032
Chapter 8 Post-Traumatic Stress Disorder Treatment Market: Competitive Analysis
                   8.1 Recent Developments And Impact Analysis, By Key Market Participants
                       8.1.1 New Product Launches
                       8.1.2 Mergers And Acquisitions
                       8.1.3 Partnerships And Strategic Collaboration
                       8.1.4 Conferences And Campaigns
                   8.2 Company Categorization
                       8.2.1 Innovators
                       8.2.2 Market Leaders
                       8.2.3 Heat Map Analysis
                   8.3 Vendor Landscape
                       8.3.1 List Of Key Distributors And Channel Partners
                       8.3.2 Key Customers
                   8.4 Key Company Market Share Analysis, 2023
                   8.5 Public Companies
                       8.5.1 Company Market Position Analysis
                       8.5.2 Competitive Dashboard Analysis
                           8.5.2.1 Market Differentiators
                   8.6 Private Companies
                       8.6.1 List Of Key Emerging Companies
                       8.6.2 Regional Network Map
                   8.7 Company Profiles
                       8.7.1 Lupin Limited
                           8.7.1.1 Company Overview
                           8.7.1.2 Financial Performance
                           8.7.1.3 Product Benchmarking
                           8.7.1.4 Strategic Initiatives
                       8.7.2 Pfizer, Inc.
                           8.7.2.1 Company Overview
                           8.7.2.2 Financial Performance
                           8.7.2.3 Product Benchmarking
                           8.7.2.4 Strategic Initiatives
                       8.7.3 Aurobindo Pharma Limited
                           8.7.3.1 Company Overview
                           8.7.3.2 Financial Performance
                           8.7.3.3 Product Benchmarking
                           8.7.3.4 Strategic Initiatives
                       8.7.4 Merck Kgaa
                           8.7.4.1 Company Overview
                           8.7.4.2 Financial Performance
                           8.7.4.3 Product Benchmarking
                           8.7.4.4 Strategic Initiatives
                       8.7.5 Glaxosmithkline Plc
                           8.7.5.1 Company Overview
                           8.7.5.2 Financial Performance
                           8.7.5.3 Product Benchmarking
                           8.7.5.4 Strategic Initiatives
                       8.7.6 Otsuka Pharmaceutical Development
                           8.7.6.1 Company Overview
                           8.7.6.2 Financial Performance
                           8.7.6.3 Product Benchmarking
                           8.7.6.4 Strategic Initiatives
                       8.7.7 Jazz Pharmaceuticals
                           8.7.7.1 Company Overview
                           8.7.7.2 Financial Performance
                           8.7.7.3 Product Benchmarking
                           8.7.7.4 Strategic Initiatives
                       8.7.8 Bionomics
                           8.7.8.1 Company Overview
                           8.7.8.2 Financial Performance
                           8.7.8.3 Product Benchmarking
                           8.7.8.4 Strategic Initiatives
                       8.7.9 Aptinyx
                           8.7.9.1 Company Overview
                           8.7.9.2 Financial Performance
                           8.7.9.3 Product Benchmarking
                           8.7.9.4 Strategic Initiatives
                       8.7.10 Astrazeneca
                           8.7.10.1 Company Overview
                           8.7.10.2 Financial Performance
                           8.7.10.3 Product Benchmarking
                           8.7.10.4 Strategic Initiatives

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert